Back to Journals

Metalloproteinases In Medicine

Dr Itoh

The Kennedy Institute of Rheumatology, University of Oxford, United Kingdom

Dr Itoh

Editor-in-Chief: Dr Yoshifumi Itoh

Yoshifumi Itoh is a Senior Lecturer of Matrix Biology at the Kennedy Institute of Rheumatology, the University of Oxford. He received his MSc in Clinical Pharmacy from the Tokyo College of Pharmacy in Japan in 1991 and joined the Department of Biochemistry and Molecular Biology at the University of Kansas Medical Center, USA. In 1996, he received his PhD from the Tokyo University of Pharmacy and Life Sciences (formerly Tokyo College of Pharmacy) with the work done in the US. In 1997 he moved back to Japan and was appointed as an Assistant Professor (Joshu) in the Department of Cancer Cell Research at the Institute of Medical Sciences, University of Tokyo. In 2001 he moved to the UK and joined the Kennedy Institute of Rheumatology, Imperial College London, where he has his own research group. In 2011 the institute was transferred to the University of Oxford, and the research building was relocated to Oxford in 2013.

His research interests have been cell invasion and tissue destructions related to arthritis and cancer. Especially he is interested in the roles and regulations of membrane-type matrix metalloproteinases that promote progression of diseases.

Editorial Board

Ulrich auf dem Keller, Professor, Department of Biotechnology and Biomedicine, Technical University of Denmark, Denmark

Ajay Kumar Chaudhary, Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute, New York, USA

Dylan Edwards, Emeritus Professor of Cancer Studies, University of East Anglia, Norwich, NR4 7TJ, UK.

Rafael Fridman, Professor, Department of Pathology, Wayne State University, Detroit, MI, USA

Jelena Gavrilovic, Cell Biology, School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, UK

Sean E. Gill, Department of Medicine/Department of Physiology and Pharmacology, Western University, Scientist, Centre for Critical Illness Research, Lawson Health Research Institute, London, Ontario, Canada

László Herszényi, Department of Gastroenterology, Medical Centre, Hungarian Defence Forces, Semmelweis University Teaching Hospital, Budapest, Hungary.

A McGarry Houghton, Associate Member, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Veli-Matti Kähäri, Professor in Dermatology, Department of Dermatology, University of Turku, Turku, Finland

Kaisa Lehti, Department of Microbiology, Tumor and Cell Biology, Karolinska institutet, Sweden.

Anne Manicone, Department of Medicine, University of Washington, Seattle, WA, USA

Ferdinando Mannello, Full Professor of Clinical Biochemistry, Department of Biomolecular Sciences; Director of the Unit of Clinical Biochemistry, University "Carlo Bo" of Urbino, Italy

Ghislain Opdenakker, MD, PhD, FRCP, Professor, Head of Immunobiology, University of Leuven, Chairman, Board of Directors, Rega Institute for Medical Research, Leuven, Belgium

William C. Parks, Founding Editor, Professor of Medicine and Biomedical Sciences, Associate Dean for Graduate Research Education, and Scientific Director of the Women’s Guild Lung Institute at Cedars-Sinai Medical Center in Los Angeles, California, USA

Irit Sagi, Professor of Biophysics and Biomedical research, Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel

Radislav Sedlacek, Director, Czech Centre for Phenogenomics and Head of Dept. of Transgenic Models of Diseases & Transgenic Unit, Institute of Molecular Genetics AV CR, vvi, Czech Republic

Tomas Vaisar, Research Professor of Medicine, Department of Medicine, University of Washington, Seattle, USA.

Steven R. Van Doren, Professor of Biochemistry, Biochemistry Department, University of Missouri, Columbia, MO, USA